Internal Medicine, Hematology & Oncology · Bronx, NY
NPI
1841289931
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2330 Eastchester Rd
Bronx, NY, 10469
Phone (718) 732-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$966K
74,402 services
Medicare patients, 2024
573
Average age 75
Drug cost, 2024
$10.7M
3,149 prescriptions
Company payments, 2025
$116
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fabio Volterra was code J1439 (injection, ferric carboxymaltose, 1 mg), 15,000 times for 18 patients. In total Fabio Volterra billed 74,402 services in 184 codes, and Medicare paid $966K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 15,000 | 18 | $0.87 | $13K |
| J0897 Injection, denosumab, 1 mg | Office | 1,500 | 13 | $20.62 | $31K |
| 36415 Venipuncture Blood Collection | Office | 1,475 | 512 | $8.65 | $13K |
| 85025 Blood Count | Office | 1,454 | 513 | $7.56 | $11K |
| 88185 Surgical Pathology Examination | Office | 1,384 | 57 | $22.11 | $31K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,166 | 27 | $0.09 | $100 |
| 80053 Clinical Chemistry | Office | 1,089 | 458 | $10.33 | $11K |
| 99214 Office E&M - Established | Office | 1,081 | 429 | $106.18 | $115K |
| 83615 Clinical Chemistry | Office | 960 | 430 | $5.90 | $5,665 |
| 84550 Clinical Chemistry | Office | 937 | 419 | $4.42 | $4,138 |
| 84100 Clinical Chemistry | Office | 931 | 412 | $4.64 | $4,315 |
| 83735 Clinical Chemistry | Office | 914 | 408 | $6.56 | $5,992 |
| 82784 Immunoassay | Office | 648 | 122 | $9.11 | $5,905 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 556 | 131 | $51.20 | $28K |
| 83550 Clinical Chemistry | Office | 428 | 218 | $8.55 | $3,659 |
By year: 2022 $1.4M for 101,098 services; 2023 $1.5M for 118,197 services; 2024 $966K for 74,402 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,475 | 512 | $8.65 | $13K |
| 85025 Blood Count | 1,454 | 513 | $7.56 | $11K |
| 88185 Surgical Pathology Examination | 1,384 | 57 | $22.11 | $31K |
| 80053 Clinical Chemistry | 1,089 | 458 | $10.33 | $11K |
| 83615 Clinical Chemistry | 960 | 430 | $5.90 | $5,665 |
| 84550 Clinical Chemistry | 937 | 419 | $4.42 | $4,138 |
| 84100 Clinical Chemistry | 931 | 412 | $4.64 | $4,315 |
| 83735 Clinical Chemistry | 914 | 408 | $6.56 | $5,992 |
| 82784 Immunoassay | 648 | 122 | $9.11 | $5,905 |
| 83550 Clinical Chemistry | 428 | 218 | $8.55 | $3,659 |
Medicare prescription drug claims, 2024
In 2024, the drug Fabio Volterra prescribed most often to Medicare patients was Letrozole, with 299 prescriptions and refills. In total Fabio Volterra wrote 3,149 Medicare prescriptions that cost $10.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 299 | 768 | 85 | $5,134 |
| Anastrozole Generic | 247 | 626 | 72 | $3,491 |
| Aranesp Darbepoetin Alfa In Polysorbat | 162 | 162 | 26 | $507K |
| Exemestane Generic | 153 | 329 | 39 | $18K |
| Revlimid Lenalidomide | 116 | 116 | 13 | $2.0M |
| Xgeva Denosumab | 111 | 140 | 24 | $336K |
| Akynzeo Fosnetupitant/Palonosetron | 103 | 103 | 21 | $114K |
| Procrit Epoetin Alfa | 94 | 94 | 16 | $289K |
| Fulvestrant Generic | 76 | 84 | 12 | $96K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 72 | 203 | 26 | $479 |
| Lupron Depot Leuprolide Acetate | 71 | 105 | 11 | $196K |
| Hydroxyurea Generic | 63 | 91 | 14 | $782 |
| Ondansetron Hcl Generic | 63 | 63 | 21 | $712 |
| Verzenio Abemaciclib | 61 | 61 | Under 11 | $941K |
| Ontruzant Trastuzumab-Dttb | 48 | 48 | Under 11 | $203K |
Brand drugs: - claims; generic drugs: 1,803 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fabio Volterra $116 ($116 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $68.49.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.